Skip to main content
Erschienen in: Heart and Vessels 4/2019

05.10.2018 | Original Article

Impact of a prolonged interatrial conduction time for predicting the recurrence of atrial fibrillation after circumferential pulmonary vein isolation of persistent atrial fibrillation

verfasst von: Satoshi Higuchi, Koichiro Ejima, Morio Shoda, Eri Yamamoto, Yuji Iwanami, Daigo Yagishita, Nobuhisa Hagiwara

Erschienen in: Heart and Vessels | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

There are some cases that are difficult to cure with only circumferential pulmonary vein isolation (CPVI) of persistent atrial fibrillation (PerAF). Recently, prolonged interatrial conduction times (IACTs), which seem to be associated with progressive remodeled atria, have been reported as a predictor of new-onset AF. This study aimed to investigate the prognostic value of a prolonged IACT for predicting AF recurrences after CPVI of PerAF. One hundred thirteen patients who underwent CPVI without an empirical substrate modification of PerAF were retrospectively analyzed. The IACT was defined as the interval from the earliest P-wave onset on the ECG to the latest activation in the coronary sinus and was measured after achieving the CPVI and conversion to sinus rhythm. During a mean 22.7-month follow-up after the initial procedure, 56 patients (50%) had AF recurrences. Patients with AF recurrence had a longer IACT than those without AF recurrence (p < 0.001). The best discriminative cut-off value for the IACT was 123 ms (sensitivity 53%, specificity 85%). In a Cox multivariate analysis, a prolonged IACT of ≥ 123 ms was the only independent predictor (hazard ratio: 2.38; 95% confidence interval: 1.36–4.16, p = 0.002) of being associated with the incidence of an AF recurrence. Even after multiple CPVI procedures, patients with an IACT ≥ 123 ms had a higher AF recurrence rate than those with an IACT < 123 ms (p = 0.002). In conclusion, a prolonged IACT of ≥ 123 ms may be a useful marker for predicting AF recurrences after both initial and multiple CPVI procedures for PerAF.
Literatur
1.
Zurück zum Zitat Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Investigators STARAFII (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822CrossRefPubMed Verma A, Jiang CY, Betts TR, Chen J, Deisenhofer I, Mantovan R, Macle L, Morillo CA, Haverkamp W, Weerasooriya R, Albenque JP, Nardi S, Menardi E, Novak P, Sanders P, Investigators STARAFII (2015) Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 372:1812–1822CrossRefPubMed
2.
Zurück zum Zitat Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921–1929CrossRefPubMed Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, Mathew S, Yoshiga Y, Wissner E, Kuck KH, Ouyang F (2012) Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg Sequential Ablation Strategy. J Am Coll Cardiol 60:1921–1929CrossRefPubMed
3.
Zurück zum Zitat Higuchi S, Sohara H, Nakamura Y, Ihara M, Yamaguchi Y, Shoda M, Hagiwara N, Satake S (2016) Is it necessary to achieve a complete box isolation in the case of frequent esophageal temperature rises? Feasibility of shifting to a partial box isolation strategy for patients with non-paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 27:897–904CrossRefPubMed Higuchi S, Sohara H, Nakamura Y, Ihara M, Yamaguchi Y, Shoda M, Hagiwara N, Satake S (2016) Is it necessary to achieve a complete box isolation in the case of frequent esophageal temperature rises? Feasibility of shifting to a partial box isolation strategy for patients with non-paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 27:897–904CrossRefPubMed
4.
Zurück zum Zitat Jaïs P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, Macle L, Raybaud F, Garrigue S, Shah DC, Le Metayer P, Clémenty J, Haïssaguerre M (2004) Technique and results of linear ablation at the mitral isthmus. Circulation 110:2996–3002CrossRefPubMed Jaïs P, Hocini M, Hsu LF, Sanders P, Scavee C, Weerasooriya R, Macle L, Raybaud F, Garrigue S, Shah DC, Le Metayer P, Clémenty J, Haïssaguerre M (2004) Technique and results of linear ablation at the mitral isthmus. Circulation 110:2996–3002CrossRefPubMed
5.
Zurück zum Zitat Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053CrossRefPubMed Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T, Khunnawat C, Ngarmukos T (2004) A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol 43:2044–2053CrossRefPubMed
6.
Zurück zum Zitat Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, Ramoul K, Komatsu Y, Roten L, Jadidi A, Linton N, Pedersen M, Daly M, O'Neill M, Knecht S, Weerasooriya R, Rostock T, Manninger M, Cochet H, Shah AJ, Yeim S, Denis A, Derval N, Hocini M, Sacher F, Haissaguerre M, Jais P (2015) Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol 8:18–24CrossRefPubMed Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, Ramoul K, Komatsu Y, Roten L, Jadidi A, Linton N, Pedersen M, Daly M, O'Neill M, Knecht S, Weerasooriya R, Rostock T, Manninger M, Cochet H, Shah AJ, Yeim S, Denis A, Derval N, Hocini M, Sacher F, Haissaguerre M, Jais P (2015) Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol 8:18–24CrossRefPubMed
7.
Zurück zum Zitat Wang YS, Chen GY, Li XH, Zhou X, Li YG (2017) Prolonged P-wave duration is associated with atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review and meta-analysis. Int J Cardiol 227:355–359CrossRefPubMed Wang YS, Chen GY, Li XH, Zhou X, Li YG (2017) Prolonged P-wave duration is associated with atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review and meta-analysis. Int J Cardiol 227:355–359CrossRefPubMed
8.
Zurück zum Zitat Blanche C, Tran N, Rigamonti F, Burri H, Zimmermann M (2013) Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Europace 15:198–204CrossRefPubMed Blanche C, Tran N, Rigamonti F, Burri H, Zimmermann M (2013) Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Europace 15:198–204CrossRefPubMed
9.
Zurück zum Zitat Chao TF, Sung SH, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Ueng KC, Wu TJ, Chen SA (2011) Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart 97:225–230CrossRefPubMed Chao TF, Sung SH, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Ueng KC, Wu TJ, Chen SA (2011) Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart 97:225–230CrossRefPubMed
10.
Zurück zum Zitat Ejima K, Kato K, Arai K, Fukushima K, Fukushima N, Suzuki T, Yoshida K, Nuki T, Uematsu S, Hoshi H, Manaka T, Ashihara K, Shoda M, Hagiwara N (2014) Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. Circ J 78:872–877CrossRefPubMed Ejima K, Kato K, Arai K, Fukushima K, Fukushima N, Suzuki T, Yoshida K, Nuki T, Uematsu S, Hoshi H, Manaka T, Ashihara K, Shoda M, Hagiwara N (2014) Impact of atrial remodeling on the outcome of radiofrequency catheter ablation of paroxysmal atrial fibrillation. Circ J 78:872–877CrossRefPubMed
11.
Zurück zum Zitat Mugnai G, Chierchia GB, de Asmundis C, Juliá J, Conte G, Sieira-Moret J, Capulzini L, Wauters K, Rodriguez-Mañero M, Ciconte G, Baltogiannis G, Di Giovanni G, Saitoh Y, Brugada P (2016) P-wave indices as predictors of atrial fibrillation recurrence after pulmonary vein isolation in normal left atrial size. J Cardiovasc Med (Hagerstown) 17:194–200CrossRef Mugnai G, Chierchia GB, de Asmundis C, Juliá J, Conte G, Sieira-Moret J, Capulzini L, Wauters K, Rodriguez-Mañero M, Ciconte G, Baltogiannis G, Di Giovanni G, Saitoh Y, Brugada P (2016) P-wave indices as predictors of atrial fibrillation recurrence after pulmonary vein isolation in normal left atrial size. J Cardiovasc Med (Hagerstown) 17:194–200CrossRef
12.
Zurück zum Zitat Deftereos S, Kossyvakis C, Efremidis M, Bouras G, Panagopoulou V, Papadimitriou C, Doudoumis K, Deftereos G, Synetos A, Davlouros P, Toutouzas K, Alexopoulos D, Manolis AS, Giannopoulos G (2014) Interatrial conduction time and incident atrial fibrillation: a prospective cohort study. Heart Rhythm 11:1095–1101CrossRefPubMed Deftereos S, Kossyvakis C, Efremidis M, Bouras G, Panagopoulou V, Papadimitriou C, Doudoumis K, Deftereos G, Synetos A, Davlouros P, Toutouzas K, Alexopoulos D, Manolis AS, Giannopoulos G (2014) Interatrial conduction time and incident atrial fibrillation: a prospective cohort study. Heart Rhythm 11:1095–1101CrossRefPubMed
13.
Zurück zum Zitat Henmi R, Ejima K, Shoda M, Yagishita D, Hagiwara N (2016) Interatrial Conduction Time Can Predict New-Onset Atrial Fibrillation After Radiofrequency Ablation of Isolated, Typical Atrial Flutter. J Cardiovasc Electrophysiol 27:1293–1297CrossRefPubMed Henmi R, Ejima K, Shoda M, Yagishita D, Hagiwara N (2016) Interatrial Conduction Time Can Predict New-Onset Atrial Fibrillation After Radiofrequency Ablation of Isolated, Typical Atrial Flutter. J Cardiovasc Electrophysiol 27:1293–1297CrossRefPubMed
14.
Zurück zum Zitat Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:528–606CrossRefPubMed Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D (2012) 2012 HRS/EHRA/ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 14:528–606CrossRefPubMed
15.
Zurück zum Zitat Ejima K, Henmi R, Iwanami Y, Yagishita D, Shoda M, Hagiwara N (2017) Comparison of the efficacy of empiric thoracic vein isolation for the treatment of paroxysmal and persistent atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 28:266–272CrossRefPubMed Ejima K, Henmi R, Iwanami Y, Yagishita D, Shoda M, Hagiwara N (2017) Comparison of the efficacy of empiric thoracic vein isolation for the treatment of paroxysmal and persistent atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol 28:266–272CrossRefPubMed
16.
Zurück zum Zitat Abecasis J, Dourado R, Ferreira A, Saraiva C, Cavaco D, Santos KR, Morgado FB, Adragão P, Silva A (2009) Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation. Europace 11:1289–1294CrossRefPubMed Abecasis J, Dourado R, Ferreira A, Saraiva C, Cavaco D, Santos KR, Morgado FB, Adragão P, Silva A (2009) Left atrial volume calculated by multi-detector computed tomography may predict successful pulmonary vein isolation in catheter ablation of atrial fibrillation. Europace 11:1289–1294CrossRefPubMed
17.
Zurück zum Zitat Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M (2001) Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol 33:2083–2094CrossRef Ausma J, Litjens N, Lenders MH, Duimel H, Mast F, Wouters L, Ramaekers F, Allessie M, Borgers M (2001) Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol 33:2083–2094CrossRef
18.
Zurück zum Zitat Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, Park CI, Denis A, Jaïs P, Hocini M, Potocnik C, Allgeier J, Hochholzer W, Herrera-Sidloky C, Kim S, Omri YE, Neumann FJ, Weber R, Haïssaguerre M, Arentz T (2016) Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics. Circ Arrhythm Electrophysiol. https://doi.org/10.1161/CIRCEP.115.002962 CrossRefPubMed Jadidi AS, Lehrmann H, Keyl C, Sorrel J, Markstein V, Minners J, Park CI, Denis A, Jaïs P, Hocini M, Potocnik C, Allgeier J, Hochholzer W, Herrera-Sidloky C, Kim S, Omri YE, Neumann FJ, Weber R, Haïssaguerre M, Arentz T (2016) Ablation of Persistent Atrial Fibrillation Targeting Low-Voltage Areas With Selective Activation Characteristics. Circ Arrhythm Electrophysiol. https://​doi.​org/​10.​1161/​CIRCEP.​115.​002962 CrossRefPubMed
19.
Zurück zum Zitat Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Shiraki T, Sunaga A, Matsuda Y, Uematsu M (2016) Influence of underlying substrate on atrial tachyarrhythmias after pulmonary vein isolation. Heart Rhythm 13:870–888CrossRefPubMed Masuda M, Fujita M, Iida O, Okamoto S, Ishihara T, Nanto K, Kanda T, Shiraki T, Sunaga A, Matsuda Y, Uematsu M (2016) Influence of underlying substrate on atrial tachyarrhythmias after pulmonary vein isolation. Heart Rhythm 13:870–888CrossRefPubMed
Metadaten
Titel
Impact of a prolonged interatrial conduction time for predicting the recurrence of atrial fibrillation after circumferential pulmonary vein isolation of persistent atrial fibrillation
verfasst von
Satoshi Higuchi
Koichiro Ejima
Morio Shoda
Eri Yamamoto
Yuji Iwanami
Daigo Yagishita
Nobuhisa Hagiwara
Publikationsdatum
05.10.2018
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2019
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1272-8

Weitere Artikel der Ausgabe 4/2019

Heart and Vessels 4/2019 Zur Ausgabe

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

PET kann infarktgefährdete Koronararterien entdecken

04.06.2024 Koronare Herzerkrankung Nachrichten

Der Nachweis aktiver Plaques mittels 18F-Natriumfluorid-PET hilft nicht nur, infarktgefährdete Patienten, sondern auch infarktgefährdete Koronararterien zu erkennen. Von einer gezielten Behandlung vulnerabler Plaques ist man trotzdem weit entfernt.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.